GF
BLUE

Gabelli Funds’s bluebird bio BLUE Stock Holding History

Gabelli Funds’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-500
Closed -$13.8K – 1113
2023
Q4 		$13.8K Sell
500
-150
-23% -$9.14K ﹤0.01% 1067
2023
Q3 		$39.5K Sell
650
-150
-19% -$10.5K ﹤0.01% 1068
2023
Q2 		$52.6K Hold
800
– – ﹤0.01% 1063
2023
Q1 		$50.9K Sell
800
-200
-20% -$22.8K ﹤0.01% 1080
2022
Q4 		$138K Sell
1,000
-300
-23% -$42.3K ﹤0.01% 1085
2022
Q3 		$165K Hold
1,300
– – ﹤0.01% 1173
2022
Q2 		$108K Sell
1,300
-750
-37% -$58.2K ﹤0.01% 1235
2022
Q1 		$199K Hold
2,050
– – ﹤0.01% 1246
2021
Q4 		$410K Sell
2,050
-1,210
-37% -$286K ﹤0.01% 1117
2021
Q3 		$807K Sell
3,260
-1,004
-24% -$287K 0.01% 953
2021
Q2 		$1.77M Hold
4,264
– – 0.01% 781
2021
Q1 		$1.67M Buy
+4,264
New +$2.1M 0.01% 780

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Gabelli Funds's BLUE Position: Q1 2024 in Review

Gabelli Funds sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 500 shares — an estimated $13.8K sold.

Gabelli Funds first reported a position in BLUE in Q1 2021 and held it in 12 quarters. The position peaked at $1.77M in Q2 2021. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Gabelli Funds reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Gabelli Funds sold 500 bluebird bio shares in Q1 2024, an estimated $13.8K.
  • Gabelli Funds first reported a position in bluebird bio in Q1 2021 and held it in 12 quarters.
  • Gabelli Funds's bluebird bio position peaked at $1.77M in Q2 2021.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Gabelli Funds's 13F filing for Q1 2024, filed 14 May 2024.